| Literature DB >> 15102331 |
Nikoletta Charizopoulou1, Silke Jansen, Martina Dorsch, Frauke Stanke, Julia R Dorin, Hans-Jürgen Hedrich, Burkhard Tümmler.
Abstract
BACKGROUND: A major boost to the cystic fibrosis disease research was given by the generation of various mouse models using gene targeting in embryonal stem cells. Moreover, the introduction of the same mutation on different inbred strains generating congenic strains facilitated the search for modifier genes. From the original CftrTgH(neoim)Hgu CF mouse model we have generated using strict brother x sister mating two inbred CftrTgH(neoim)Hgu mouse lines (CF/1 and CF/3). Thereafter, the insertional mutation was introgressed from CF/3 into three inbred backgrounds (C57BL/6, BALB/c, DBA/2J) generating congenic animals. In every backcross cycle germline transmission of the insertional mutation was monitored by direct probing the insertion via Southern RFLP. In order to bypass this time consuming procedure we devised an alternative PCR based protocol whereby mouse strains are differentiated at the Cftr locus by Cftr intragenic microsatellite genotypes that are tightly linked to the disrupted locus.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15102331 PMCID: PMC419339 DOI: 10.1186/1471-2156-5-6
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
Figure 1Generation of the a) Insertional disruption of the murine Cftr gene and predicted gene structure as described by Dorin et al. (1992). Abbreviations: S, SalI; H, HindIII; X, XbaI. Map position of the CFneo1 and CFneo2 products is also indicated. b) Genotype analysis of heterozygous cf/+ matings. The probe 1.2H issued in order to identify via Southern hybridisation the congenic mice which carry the insertion. DNAs were digested with XbaI+SalI and probed with 1.2H. The upper hybridising fragment of 6.6 Kb represents the wild type allele, the lower 5 Kb fragment is diagnostic for the insertional mutation.
Figure 2Microsatellite genotyping. a) Localisation of the intragenic polymorphisms on the physical map of the murine Cftr gene. b) Analysis of the four informative intragenic microsatellites by direct blotting electrophoresis. c) Microsatellite alleles were ascertained by arbitary repeat units. The alleles for all four microsatellites which are representative of the two CF inbred lines (CF/1 and CF/3)and hence directly linked with the disease causing allele carrying the insertional vector pIV3.5H in Cftr exon 10 have been given the number 20.
Expected Southern and microsatellite genotypes for animals backcrossed to the three inbred backgrounds.
| 16/16 | 31/31 | 30/30 | |||
| 16/20 | 31/20 | 30/20 | |||
| 20/20 | 20/20 | 20/20 | |||
| 14/14 | 35/35 | 21/21 | |||
| 20/14 | 20/35 | 20/31 | |||
| 20/20 | 20/20 | 20/20 | |||
| 16/16 | 44/44 | 32/32 | |||
| 20/16 | 20/44 | 20/32 | |||
| 20/20 | 20/20 | 20/20 |
Genotypes of the animals with an excised vector. Mouse A in one chromosome, Mouse B in both chromosomes.
| cf/n | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) | |
| n/n | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) |
Primer sequences used for the amplification of the long range products.
| Cftr-5012 | CCT TCC ATG TAC CCC TCC TCA CTT | 5012 bp | Wild type |
| CCC GGC ATA ATC CAA GAA AAT TG | |||
| Cftr-5198 | TGT GGG AAA TCC TGT GCT GAA A | 5198 bp | mutant |
| CTT CCG GCT CGT ATG TTG TGT T | |||
| Cftr-3736 | CAC ACA ACA TAC GAG CCG GAA G | 3736 bp | mutant |
| TTT ATT GCC GAT CCC CTC AGA A | |||
| Cftr-3473 | CTC GTG CTT TAC GGT ATC GCC | 3473 bp | mutant |
| TGC TGT AGT TGG CAA GCT TTG A |
Figure 3Long range PCR. a) Map position of the long range PCR product corresponding to the 5012 bp wild type sequence. b) Map position of the three long range products corresponding to the mutant allele. c) Representative agarose gel (1%) indicating the expected PCR products for all four primer sets.
Primer sequences used for primer walking spanning the entire region from Cftr exon 9 to Cftr intron 10. Location based on the Genome Database Cftr sequence (AF 162137)
| NCEx9I9-A | 197720- 197742 | TTT GGG GAA TTA CTG GAG AAA G | 419 bp |
| NCEx9I9-B | 198138- 198117 | AGC TCG CTG ATA GGT TAT CCA | |
| NC10-A | 198002-198023 | CCC CTC CTC ACT TCC ATT AAA | 400 bp |
| NC10-B | 198402-198381 | TTT AAG GCT CAG GGC TAA TTG | |
| NC11-A | 198376- 198396 | TTC CAC AAT TAG CCC TGA GC | 649 bp |
| NC11-B | 199024- 199001 | TGA AGG AAA TCA TTA CTG AAG CA | |
| NC12-A | 199001- 199024 | TGC TTC AGT AAT GAT TTC CTT CA | 550 bp |
| NC12-B | 199551- 199531 | TAT GGA TCC CCA CAG CAA GT | |
| NC13-A | 199394- 199414 | CTC AGG GAT TGT CAC GGT TT | 563 bp |
| NC13-B | 199966- 199946 | GCT TTG ATC TCT GGG AGC AC | |
| NC14-A | 199741- 199763 | GAT CAC AGG AGC CTA GCA TAG A | 550 bp |
| NC14-B | 200290- 200268 | TTC ACT TTA CAT CCT GGC TTC A | |
| NC15-A | 200122- 200142 | ACT GGG AGA GGA TGC AAA AA | 575 bp |
| NC15-B | 200696- 200676 | CCC AGT GTG AGA AGA TGC AC | |
| NC16-A | 200572- 200592 | TGC TCC CAG AAA TCT TCA CC | 582 bp |
| NC16-B | 201153- 201133 | AGT TGT CAG AAG GGA ACC CA | |
| NC17-A | 201134- 201154 | TGG GTT CCC TTC TGA CAA CT | 582 bp |
| NC17-B | 201715- 201695 | TTA GGT CCC CGT GCT TAC AC | |
| NC19-A | 201739- 201759 | TAG GTG GAT CCA TAA CCC CA | 480 bp |
| NC19-B | 202219- 202199 | GGA CAG AGA AGC AGG AGT GG | |
| NC20-A | 202199- 202219 | CCA CTC CTG CTT CTC TGT CC | 487 bp |
| NC20-B | 202686- 202666 | AAA GAA GAG CGA GCC CCT AC | |
| NCI9Ex10-A | 202593- 202612 | CCA TAG CCC AAG AGC TTT CA | 413 bp |
| NCI9Ex10-B | 203007-202987 | GTA CCC GGC ATA ATC CAA GA | |
| NCEx10I10-A | 202986-203006 | TTC TTG GAT TAT GCC GGG TA | 403 bp |
| NCEx10I10-B | 203387-203367 | TTT CCA GTT GGG GGT ACA CT | |
| NC21-A | 203296- 203316 | GGG CTT CAA GGC CTA ATT CT | 479 bp |
| NC21-B | 203775- 203755 | ATG TGA TCC AGA CTG GCC TA | |
| NC22-A | 203654- 203674 | ATG CAT GGG GTG TGG TAC TT | 625 bp |
| NC22-B | 204277- 204255 | TCC AAT GAT CTA CCT GTG TCC A |
Figure 4Primer walking. Straight lines represent the fragment amplified by each primer set, overlapping sequences are represented by boxes.
Mouse A and B littermate genotypes.
| cf/n | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) | |
| cf/n | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) | |
| n/n | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) | |
| cf/cf | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) | |
| cf/cf | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) | |
| cf/cf | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) | |
| cf/cf | cf/cf (20/20) | cf/cf (20/20) | cf/cf (20/20) |
Primer sequences used for the amplification of the intragenic Cftr microsatellites. The forward primer is 5'biotinylated.
| D6NC1-A | BIOTIN-TGC TTG AGC TAT CCA TTC TGA |
| D6NC1-B | TAC CCA ATG TTG CCA TCT GA |
| D6NC2-A | BIOTIN-TTG GAA GTG AGG ATT GCC TT |
| D6NC2-B | TGC CTC AGT CTC ATA TTA TTG C |
| D6NC3-A | BIOTIN-TCT CAG CCT GTC TTC CTC TCA |
| D6NC3-B | TCC TCC CAA AAC AGC TTC AC |
| D6NC4-A | BIOTIN-GAG TTG GAG AGG CTG TTT GG |
| D6NC4-B | TGT GCC AGG ACA CTG TGA CT |
| D6NC5-A | BIOTIN-TTC AAA TGA CCA AAA TCC CC |
| D6NC5-B | TGG CAA ATT TTC AAC AAC AAA |
Primer sequences used for the amplification of the Cftr intron 9-pMC1 vector plasmid sequence (CFneo2) and the neomycin-Cftr intron 9 (CFneo1) products.
| CFneo 1-A | CGT TGG CTA CCC GTG ATA TT | 332 bp |
| CFneo 1-B | CTT CCA CAA GGC TTC CTG AG | |
| CFneo2-A | CCT GAT GTT GAT TTT GGG AGA | 253 bp |
| CFneo2-B | ATT AAT GCA GCT GGC ACG AC |